Ensuring the long- and short-term success of cancer control policies and initiatives is central to the work of comprehensive cancer coalitions. Our September NCI Research to Reality cyber-seminar is part of an occasional series which highlights how the lessons derived from implementation science informs, strengthens and sustains this essential work.
Past Cyber Seminars
Can a story be your most effective cancer control tool? Stories help us remember, shape our identity, and influence how we see the world. Our July NCI Research to Reality cyber-seminar will examine the role of effective narratives in cancer control prevention and implementation. Join us in a wide-ranging discussion of the power of story-telling ---- not just as a “communication channel” but the research behind what makes for an effective narrative.
Creating environments where healthy behaviors are socially supported and accessible is essential in preventing cancer and reducing health disparities. In our May NCI Research to Reality cyber-seminar, we will highlight two innovative and successful interventions designed to redress these challenges in Latino communities.
The negative impact of tobacco use on the short and long term prognosis of cancer patients and survivors is increasingly well-understood. Over the next three months, the Comprehensive Cancer Control National Partnership will lead a concerted effort to highlight key research and intervention findings to address this issue.
The NCI Research to Reality cyber-seminar kicks off this three-part series by highlighting two innovative and successful interventions designed to deliver evidence-based tobacco control interventions to patients and survivors.
Worksite wellness programs are drawing increasing attention for their promise in reducing the burden of cancer and improving the quality of life of cancer survivors. NCI’s April Research to Reality cyber-seminar will examine two worksite wellness initiatives that have implemented effective and innovative policy, systems, and environmental changes.
Colorectal cancer (CRC) is the second leading cause of cancer death in the United States. Yet CRC is 90% curable with timely detection and appropriate treatment of precancerous polyps; increased screening could reduce incidence by up to 50%. As part of our focus for CRC Awareness Month, our March cyber-seminar will examine two promising initiatives which are proving effective in increasing CRC screening rates.
This year, we celebrate the 5th Anniversary of the NCI Research to Reality community of practice. R2R was developed to engage researchers and practitioners in an ongoing discussion around moving cancer control research into practice. R2R will only be partially successful if we fail to build capacity for others to join this essential conversation.
Clinical trials are a critical resource for the discovery and development of better prevention, diagnostic and treatment methods for cancer. Many of today’s most effective prevention and treatment modalities are based upon previous clinical trial results.
Human papillomaviruses (HPV) cause most cases of cervical cancer and large proportions of vaginal, vulvar, anal, penile, and oropharyngeal cancers. HPV vaccines could dramatically reduce the incidence of HPV-associated cancers and other conditions among both females and males, but the uptake of vaccines has fallen short of target levels.